CLINICAL SUPPLY PLANNING RESOURCES

• The Patient-Centric Clinical Supply Chain For Cell And Gene Therapies

  This article explores how delivering cell and gene therapies to patients requires new levels of agility, flexibility and innovation in the logistical management of supply. 

• Controlling Complexity (Not Cost) Of Advanced Therapy Supply Chains

  Due to the short shelf life and clinical criticality of advanced therapies, their supply chains are often highly complex.  Once efficacy and safety is demonstrated, the focus of advanced therapy developers moves to controlling cost.  However, the biggest cost within the supply chain is caused by its complexity.  In this article, we will share why the advanced therapy supply chain is so complex and how this complexity correlates to cost.

• Overcoming Cell Therapy Supply Chain Challenges

  For the industry to realize the potential of cell and gene therapies (CGTs), we must develop improved solutions that reliably support the control and transport of critical CGT raw materials and products.

• Cell & Gene Therapy Supply Chain Challenges: Global, Integrated Solutions

  Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.

• Building Robust Clinical Supply Chains To Support Global Trials

  Ensuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.

• Creating Accurate, Efficient, And Effective CDMO Project Proposals

  To receive the most comprehensive project proposal possible, it is important to fill out any questionnaire as accurately and completely as possible.

• Essential Up-Front Planning For Your Clinical Trial

  Early planning mitigates risk by avoiding stock outs and study delays, minimizing waste with optimized inventory, and forecasting demand to facilitate robust supply planning.